S&P 500   2,714.83 (+2.08%)
DOW   23,172.49 (+2.29%)
QQQ   198.95 (+1.30%)
AAPL   264.57 (+1.98%)
FB   171.18 (+1.56%)
MSFT   164.76 (+0.78%)
GOOGL   1,201.40 (+1.59%)
AMZN   2,025.37 (+0.68%)
CGC   14.95 (+3.10%)
NVDA   265.54 (+2.51%)
BABA   195.03 (-1.50%)
MU   48.27 (+3.72%)
GE   7.23 (+2.84%)
TSLA   544.54 (+0.06%)
AMD   48.55 (+2.08%)
T   29.45 (-2.09%)
ACB   0.84 (+6.31%)
F   4.99 (+5.94%)
NFLX   371.10 (-0.32%)
BAC   23.13 (+4.47%)
GILD   73.80 (-0.94%)
DIS   101.87 (+0.62%)
PRI   93.74 (+6.45%)
S&P 500   2,714.83 (+2.08%)
DOW   23,172.49 (+2.29%)
QQQ   198.95 (+1.30%)
AAPL   264.57 (+1.98%)
FB   171.18 (+1.56%)
MSFT   164.76 (+0.78%)
GOOGL   1,201.40 (+1.59%)
AMZN   2,025.37 (+0.68%)
CGC   14.95 (+3.10%)
NVDA   265.54 (+2.51%)
BABA   195.03 (-1.50%)
MU   48.27 (+3.72%)
GE   7.23 (+2.84%)
TSLA   544.54 (+0.06%)
AMD   48.55 (+2.08%)
T   29.45 (-2.09%)
ACB   0.84 (+6.31%)
F   4.99 (+5.94%)
NFLX   371.10 (-0.32%)
BAC   23.13 (+4.47%)
GILD   73.80 (-0.94%)
DIS   101.87 (+0.62%)
PRI   93.74 (+6.45%)
S&P 500   2,714.83 (+2.08%)
DOW   23,172.49 (+2.29%)
QQQ   198.95 (+1.30%)
AAPL   264.57 (+1.98%)
FB   171.18 (+1.56%)
MSFT   164.76 (+0.78%)
GOOGL   1,201.40 (+1.59%)
AMZN   2,025.37 (+0.68%)
CGC   14.95 (+3.10%)
NVDA   265.54 (+2.51%)
BABA   195.03 (-1.50%)
MU   48.27 (+3.72%)
GE   7.23 (+2.84%)
TSLA   544.54 (+0.06%)
AMD   48.55 (+2.08%)
T   29.45 (-2.09%)
ACB   0.84 (+6.31%)
F   4.99 (+5.94%)
NFLX   371.10 (-0.32%)
BAC   23.13 (+4.47%)
GILD   73.80 (-0.94%)
DIS   101.87 (+0.62%)
PRI   93.74 (+6.45%)
S&P 500   2,714.83 (+2.08%)
DOW   23,172.49 (+2.29%)
QQQ   198.95 (+1.30%)
AAPL   264.57 (+1.98%)
FB   171.18 (+1.56%)
MSFT   164.76 (+0.78%)
GOOGL   1,201.40 (+1.59%)
AMZN   2,025.37 (+0.68%)
CGC   14.95 (+3.10%)
NVDA   265.54 (+2.51%)
BABA   195.03 (-1.50%)
MU   48.27 (+3.72%)
GE   7.23 (+2.84%)
TSLA   544.54 (+0.06%)
AMD   48.55 (+2.08%)
T   29.45 (-2.09%)
ACB   0.84 (+6.31%)
F   4.99 (+5.94%)
NFLX   371.10 (-0.32%)
BAC   23.13 (+4.47%)
GILD   73.80 (-0.94%)
DIS   101.87 (+0.62%)
PRI   93.74 (+6.45%)
Log in

NASDAQ:ZFGNZafgen News Headlines

$0.74
-0.01 (-0.68 %)
(As of 04/8/2020 12:14 PM ET)
Add
Compare
Today's Range
$0.73
Now: $0.74
$0.77
50-Day Range
$0.66
MA: $0.97
$1.30
52-Week Range
$0.62
Now: $0.74
$2.96
Volume470 shs
Average Volume224,948 shs
Market Capitalization$27.91 million
P/E RatioN/A
Dividend YieldN/A
Beta0.21

Headlines

Zafgen (NASDAQ ZFGN) News Headlines

Source:
DateHeadline
Zafgen Inc (NASDAQ:ZFGN) Given Average Recommendation of "Hold" by BrokeragesZafgen Inc (NASDAQ:ZFGN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 19 at 8:17 AM
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswireZafgen Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswire
www.globenewswire.com - March 6 at 8:54 AM
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results - BenzingaZafgen Reports Fourth Quarter and Full Year 2019 Financial Results - Benzinga
www.benzinga.com - March 5 at 7:46 PM
Zafgen Reports Fourth Quarter and Full Year 2019 Financial ResultsZafgen Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 5 at 7:46 PM
Zafgen, Inc. Strengthens Executive Leadership Team with Appointment of Industry Veteran Priya Singhal as Head of Research andZafgen, Inc. Strengthens Executive Leadership Team with Appointment of Industry Veteran Priya Singhal as Head of Research and
www.bloomberg.com - February 16 at 6:31 PM
Form SC 13G ZAFGEN, INC. Filed by: RENAISSANCE TECHNOLOGIES LLC - StreetInsider.comForm SC 13G ZAFGEN, INC. Filed by: RENAISSANCE TECHNOLOGIES LLC - StreetInsider.com
www.streetinsider.com - February 12 at 2:27 PM
BRIEF-Sphera Funds Management Ltd Reports Passive Stake Of 7.59% In Zafgen Inc As Of February 7, 2020 - SEC Filing - ReutersBRIEF-Sphera Funds Management Ltd Reports Passive Stake Of 7.59% In Zafgen Inc As Of February 7, 2020 - SEC Filing - Reuters
www.reuters.com - February 11 at 6:06 PM
5 Deep-Value Stocks for 2020 - Yahoo Finance5 Deep-Value Stocks for 2020 - Yahoo Finance
finance.yahoo.com - December 30 at 3:27 PM
Form SC 13D ZAFGEN, INC. Filed by: CHONDRIAL THERAPEUTICS HOLDINGS, LLC - StreetInsider.comForm SC 13D ZAFGEN, INC. Filed by: CHONDRIAL THERAPEUTICS HOLDINGS, LLC - StreetInsider.com
www.streetinsider.com - December 30 at 3:27 PM
5 Deep-Value Stocks for 20205 Deep-Value Stocks for 2020
finance.yahoo.com - December 30 at 3:27 PM
The Daily Biotech Pulse: Seattle Genetics Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For AntibioticThe Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic
finance.yahoo.com - December 19 at 11:25 AM
Gold steadies; palladium retreats after surge towards $2,000/oz - NasdaqGold steadies; palladium retreats after surge towards $2,000/oz - Nasdaq
www.nasdaq.com - December 18 at 5:21 PM
BUZZ-U.S. STOCKS ON THE MOVE-FedEx, PG&E, Cigna, Halliburton - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-FedEx, PG&E, Cigna, Halliburton - Nasdaq
www.nasdaq.com - December 18 at 12:21 PM
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement - GlobeNewswireZafgen and Chondrial Therapeutics Announce Definitive Merger Agreement - GlobeNewswire
www.globenewswire.com - December 18 at 7:21 AM
Zafgen Reports Third Quarter 2019 Financial Results - StreetInsider.comZafgen Reports Third Quarter 2019 Financial Results - StreetInsider.com
www.streetinsider.com - November 7 at 12:42 PM
Zafgen Reports Third Quarter 2019 Financial Results Nasdaq:ZFGN - GlobeNewswireZafgen Reports Third Quarter 2019 Financial Results Nasdaq:ZFGN - GlobeNewswire
www.globenewswire.com - November 6 at 8:00 PM
Zafgen Reports Third Quarter 2019 Financial ResultsZafgen Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 6 at 8:00 PM
Five things you need to know in Boston business news and no spoilers please - Boston Business JournalFive things you need to know in Boston business news and no spoilers please - Boston Business Journal
www.bizjournals.com - September 23 at 4:34 PM
Zafgen plans deeper cuts to workforce after another FDA setback - Boston Business JournalZafgen plans deeper cuts to workforce after another FDA setback - Boston Business Journal
www.bizjournals.com - September 21 at 4:04 PM
Zafgen plans deeper cuts to workforce after another FDA setbackZafgen plans deeper cuts to workforce after another FDA setback
finance.yahoo.com - September 20 at 8:43 PM
Form SC 13G ZAFGEN, INC. Filed by: 683 Capital Management, LLC - StreetInsider.comForm SC 13G ZAFGEN, INC. Filed by: 683 Capital Management, LLC - StreetInsider.com
www.streetinsider.com - September 17 at 5:09 AM
Yumanity Therapeutics Appoints Patricia Allen to its Board of Directors - Business WireYumanity Therapeutics Appoints Patricia Allen to its Board of Directors - Business Wire
www.businesswire.com - September 5 at 1:59 PM
Zafgen to Explore Strategic Alternatives Nasdaq:ZFGN - GlobeNewswireZafgen to Explore Strategic Alternatives Nasdaq:ZFGN - GlobeNewswire
www.globenewswire.com - September 5 at 1:59 PM
Emerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations - Yahoo FinanceEmerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations - Yahoo Finance
finance.yahoo.com - August 27 at 9:11 AM
Emerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations - GlobeNewswireEmerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations - GlobeNewswire
www.globenewswire.com - August 26 at 9:00 AM
Zafgen Reports Second Quarter 2019 Operating and Financial Results - GlobeNewswireZafgen Reports Second Quarter 2019 Operating and Financial Results - GlobeNewswire
globenewswire.com - August 10 at 11:20 AM
Zafgen Reports Second Quarter 2019 Operating and Financial ResultsZafgen Reports Second Quarter 2019 Operating and Financial Results
finance.yahoo.com - August 9 at 1:11 AM
Zafgen to Present at the Wedbush PacGrow Healthcare Conference - Yahoo FinanceZafgen to Present at the Wedbush PacGrow Healthcare Conference - Yahoo Finance
finance.yahoo.com - August 6 at 10:46 PM
Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061 - GlobeNewswireZafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061 - GlobeNewswire
globenewswire.com - July 27 at 12:49 AM
Zafgen (ZFGN) Announces Agreement with FDA on New Nonclinical Study Design for ZGN-1061 - StreetInsider.comZafgen (ZFGN) Announces Agreement with FDA on New Nonclinical Study Design for ZGN-1061 - StreetInsider.com
www.streetinsider.com - July 24 at 8:13 PM
Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061
finance.yahoo.com - July 24 at 8:13 PM
How Many Zafgen, Inc. (NASDAQ:ZFGN) Shares Do Institutions Own? - Yahoo FinanceHow Many Zafgen, Inc. (NASDAQ:ZFGN) Shares Do Institutions Own? - Yahoo Finance
finance.yahoo.com - July 18 at 6:41 PM
How Many Zafgen, Inc. (NASDAQ:ZFGN) Shares Do Institutions Own?How Many Zafgen, Inc. (NASDAQ:ZFGN) Shares Do Institutions Own?
finance.yahoo.com - July 18 at 6:41 PM
Is Zafgen Inc (ZFGN) A Good Stock To Buy? - Yahoo FinanceIs Zafgen Inc (ZFGN) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - June 26 at 8:56 AM
Is Zafgen Inc (ZFGN) A Good Stock To Buy?Is Zafgen Inc (ZFGN) A Good Stock To Buy?
finance.yahoo.com - June 26 at 8:56 AM
Zafgen to Present at the JMP Securities Life Sciences Conference - GlobeNewswireZafgen to Present at the JMP Securities Life Sciences Conference - GlobeNewswire
globenewswire.com - June 14 at 8:58 AM
Zafgen to Present at the JMP Securities Life Sciences Conference - NasdaqZafgen to Present at the JMP Securities Life Sciences Conference - Nasdaq
www.nasdaq.com - June 13 at 7:28 PM
Zafgen to Present at the JMP Securities Life Sciences ConferenceZafgen to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 7:28 PM
Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Associations 79th Scientific Sessions - Yahoo FinanceZafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions - Yahoo Finance
finance.yahoo.com - June 12 at 5:07 PM
Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Associations 79th Scientific Sessions - GlobeNewswireZafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions - GlobeNewswire
globenewswire.com - June 10 at 9:20 AM
Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Associations 79th Scientific SessionsZafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions
finance.yahoo.com - June 10 at 9:20 AM
Zafgen provides regulatory update on ZGN-1061; shares down 5% premarket - Seeking AlphaZafgen provides regulatory update on ZGN-1061; shares down 5% premarket - Seeking Alpha
seekingalpha.com - May 31 at 8:52 AM
Mid-Afternoon Market Update: BOS Better Online Solutions Falls After Q1 Results; Organovo Holdings Shares Rise - NasdaqMid-Afternoon Market Update: BOS Better Online Solutions Falls After Q1 Results; Organovo Holdings Shares Rise - Nasdaq
www.nasdaq.com - May 30 at 6:19 PM
Mid-Morning Market Update: Markets Open Higher; Dollar General Tops Q1 Expectations - NasdaqMid-Morning Market Update: Markets Open Higher; Dollar General Tops Q1 Expectations - Nasdaq
www.nasdaq.com - May 30 at 6:19 PM
MiMedx Group and BioCryst Pharmaceuticals among healthcare gainers; Amicus Therapeutics and ReWalk Robotics among losers - Seeking AlphaMiMedx Group and BioCryst Pharmaceuticals among healthcare gainers; Amicus Therapeutics and ReWalk Robotics among losers - Seeking Alpha
seekingalpha.com - May 30 at 6:19 PM
Zafgen Announces Regulatory Update on ZGN-1061 Nasdaq:ZFGN - GlobeNewswireZafgen Announces Regulatory Update on ZGN-1061 Nasdaq:ZFGN - GlobeNewswire
globenewswire.com - May 30 at 6:19 PM
Micro-Cap Biotech Zafgen Plunges To Record Low: What You Need To KnowMicro-Cap Biotech Zafgen Plunges To Record Low: What You Need To Know
feeds.benzinga.com - May 30 at 11:05 AM
Zafgen (ZFGN) announces receipt of minutes from its Type A meeting with the FDA - StreetInsider.comZafgen (ZFGN) announces receipt of minutes from its Type A meeting with the FDA - StreetInsider.com
www.streetinsider.com - May 30 at 8:53 AM
Zafgen Announces Regulatory Update on ZGN-1061Zafgen Announces Regulatory Update on ZGN-1061
finance.yahoo.com - May 30 at 8:53 AM
Zafgen Reports First Quarter 2019 Operating and Financial Results - Yahoo FinanceZafgen Reports First Quarter 2019 Operating and Financial Results - Yahoo Finance
finance.yahoo.com - May 10 at 8:53 AM
This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel